Inhibitory Effect of PIK-24 on Respiratory Syncytial Virus Entry by Blocking Phosphatidylinositol-3 Kinase Signaling
- 1 October 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (10)
- https://doi.org/10.1128/AAC.00608-20
Abstract
Phosphoinositide-3 kinase signaling modulates many cellular processes, including cell survival, proliferation, differentiation, and apoptosis. Currently, it is known that the establishment of respiratory syncytial virus infection requires phosphoinositide-3 kinase signaling. However, the regulatory pattern of phosphoinositide-3 kinase signaling or its corresponding molecular mechanism during respiratory syncytial virus entry remains unclear. Here, the involvement of phosphoinositide-3 kinase signaling in respiratory syncytial virus entry was studied. PIK-24, a novel compound designed with phosphoinositide-3 kinase as a target, had potent anti-respiratory syncytial virus activity both in vitro and in vivo. PIK-24 significantly reduced viral entry into the host cell through blocking the late stage of the fusion process. In a mouse model, PIK-24 effectively reduced the viral load and alleviated inflammation in lung tissue. Subsequent studies on the antiviral mechanism of PIK-24 revealed that viral entry was accompanied by phosphoinositide-3 kinase signaling activation, downstream RhoA and cofilin upregulation, and actin cytoskeleton rearrangement. PIK-24 treatment significantly reversed all these effects. The disruption of actin cytoskeleton dynamics or the modulation of phosphoinositide-3 kinase activity by knockdown also affected viral entry efficacy. Altogether, it is reasonable to conclude that the antiviral activity of PIK-24 depends on the phosphoinositide-3 kinase signaling and that the use of phosphoinositide-3 kinase signaling to regulate actin cytoskeleton rearrangement plays a key role in respiratory syncytial virus entry.Funding Information
- National Natural Science Foundation of China (No. 81673670 81973190)
This publication has 49 references indexed in Scilit:
- Host Cell Entry of Respiratory Syncytial Virus Involves Macropinocytosis Followed by Proteolytic Activation of the F ProteinPLoS Pathogens, 2013
- Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial CellsJournal of Virology, 2012
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these yearsVirus Research, 2011
- Subversion of the actin cytoskeleton during viral infectionNature Reviews Microbiology, 2011
- New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 InfectionOnline Journal of Public Health Informatics, 2011
- Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entryJournal of General Virology, 2010
- Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinProceedings of the National Academy of Sciences of the United States of America, 2009
- Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola VirusPLoS Pathogens, 2008
- Viral and Host Factors in Human Respiratory Syncytial Virus PathogenesisJournal of Virology, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007